Delivery Order SPE2DB22D3019-SPE2DB25FK3FD
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.51 firm-fixed-price delivery order is for the supply of 4566802887 LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,885.97, is for the delivery of 4567615863 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 19, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,783.60, is a delivery order contract for the delivery of 4567197460 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of February 7, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.88, is for the delivery of 4567502070 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract has an ultimate completion date of March 10, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LISDEXAMFETAMINE 10 MG CAPSULE 100S. The Delivery Order is valued at $3,487.05 and has a performance period through March 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This federal contract award, valued at $1,301.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567394902 - LISDEXAMFETAMINE 10 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract....
- This federal contract award, valued at $2,328.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567038547 - LISDEXAMFETAMINE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,834.44 and an ultimate completion date of May 29, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp is the prime contractor for this award and has previously been awarded a...
- This federal contract award, with the ID SPE2DB20D2002|SPE2DB25FL23X, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $3,714.92, is a delivery order for the provision of 4567418434 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract has a firm fixed price pricing type and an ultimate completion date of March 3, 2025. This award is associated with a...
- This federal contract award, valued at $15,076.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566963272 - LISDEXAMFETAMINE 40 MG CAPSULE 100S, a prescription medication, with a period of performance through January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK3FDDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,684.12, is for the delivery of 4567501343 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of March 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/5/25 |